US: Implant Sciences has signed its second Cooperative Research and Development Agreement (CRADA) with the US Department of Homeland Security's Transportation Security Laboratory (TSL). The Company's first CRADA with the TSL for its QS-B220 desktop explosives trace detector (ETD) began November, 2011. The purpose of the new 12-month CRADA is for the TSL to use the QS-B220, having passed TSA qualification testing, as a gold standard explosives trace detector. Information gathered with the QS-B220 at the TSL will be shared with Implant Sciences and used by the Company to develop next generation trace detection technology.
TSL's core mission is to enhance homeland security, including the research, development and validation of solutions to detect and mitigate the threat of improvised explosive devices (IEDs). TSL, part of the DHS Science and Technology Directorate (S&T), establishes CRADAs as public-private partnerships designed to expeditiously mature and deploy security technologies and to prepare products to achieve Transportation Security Administration (TSA) certification/qualification. TSL conducts research, test and, evaluation at its 110 acre facility located at the FAA William J Hughes Technical Center, Atlantic City International Airport, New Jersey. "Our first CRADA with the TSL provided critical input, which was used to improve the performance of our QS-B220 to meet the TSA's standards. We believe that the partnership that was developed and the valuable feedback we received from the endeavor helped us tremendously in the QS-B220 attaining the TSA's qualified status for air cargo screening and in passing the QT&E portion of the TSA qualification for checkpoint and checked baggage,” said Todd Silvestri, Implant Sciences' Vice President of Technology.
Source: PR newswire
